Drugs targeting platelet activation/inhibition
Thrombosis (Atherosclerosis, Coronary Artery Disease, Cerebral Infarction)
ResearchActive
Key Facts
Indication
Thrombosis (Atherosclerosis, Coronary Artery Disease, Cerebral Infarction)
Phase
Research
Status
Active
Company
About Xueji Biotechnology
A stem cell biotech using iPSC-derived platelets to create off-the-shelf cell therapies for thrombocytopenia and develop related drugs.
View full company profile